Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:1178-1185

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Largo, R.
Right arrow Articles by Egido, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Largo, R.
Right arrow Articles by Egido, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*QUINAPRIL HYDROCHLORIDE

(Hypertension. 1997;29:1178-1185.)
© 1997 American Heart Association, Inc.


Articles

Endothelin-1 Upregulation in the Kidney of Uninephrectomized Spontaneously Hypertensive Rats and Its Modification by the Angiotensin-Converting Enzyme Inhibitor Quinapril

Raquel Largo; Dulcenombre Gómez-Garre; Xue Hui Liu; Javier Alonso; Julia Blanco; Juan J. Plaza; ; Jesús Egido

From the Renal Research Laboratory Fundación Jiménez Díaz, Universidad Autónoma, and the Department of Pathology (J.B.), Hospital Clínico, Universidad Complutense, Madrid, Spain.

Correspondence to Jesús Egido, MD, Servicio Nefrologia, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, 28040 Madrid. E-mail egido{at}alpha2.ft.uam.es

Abstract Endothelin (ET-1) is a potent vasoconstrictor that plays an important role in the control of renal circulation and tubular function. The contribution of this peptide to the pathogenesis of systemic hypertension and renal failure remains largely undefined. In spontaneously hypertensive rats (SHR) uninephrectomized at 20 weeks of age (UNX-SHR) and followed until 45 weeks of age, we determined ET-1 gene expression in renal tissue by reverse transcription–polymerase chain reaction and its localization by in situ hybridization in paraffin-embedded kidney sections. Age-matched SHR and normotensive Wistar-Kyoto (WKY) rats were chosen as controls. At the end of the follow-up, UNX-SHR had high systolic blood pressure, intense proteinuria, mesangial expansion, focal and segmental glomerular sclerosis, and tubulointerstitial lesions. In relation to WKY and SHR, UNX-SHR exhibited an increase in ET-1 gene expression in renal cortex and medulla. By in situ hybridization and immunoperoxidase staining, an overexpression of ET-1 gene and protein were seen in mesangial and glomerular epithelial cells and in some proximal tubules and vessels. Angiotensin-converting enzyme (ACE) activity was significantly increased in the renal brush border. Since in mesangial cells, angiotensin II induces ET-1 synthesis, a group of UNX-SHR received the ACE inhibitor quinapril from the time of UNX. These animals had a decrease in blood pressure, proteinuria, and serum and brush border ACE activity and in the expression and synthesis of ET-1 in all renal areas. On the whole, these data show that UNX-SHR have an upregulation of ET-1 gene and protein in several structures of the kidney compared with SHR and WKY rats. Quinapril diminished ACE activity and ET-1 expression and synthesis coincidentally with an improvement in proteinuria and morphological lesions. The beneficial effects of ACE inhibitors may be due to the diminution of both angiotensin II and ET-1 generation.


Key Words: kidney • rats, inbred SHR • endothelin-1 • ACE inhibition




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
E. Gagliardini, D. Corna, C. Zoja, F. Sangalli, F. Carrara, M. Rossi, S. Conti, D. Rottoli, L. Longaretti, A. Remuzzi, et al.
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1448 - F1456.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. M. Richter
Role of endothelin in chronic renal failure--developments in renal involvement
Rheumatology, October 1, 2006; 45(suppl_3): iii36 - iii38.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sorokin and D. E. Kohan
Physiology and pathology of endothelin-1 in renal mesangium
Am J Physiol Renal Physiol, October 1, 2003; 285(4): F579 - F589.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. Moridaira, J. Morrissey, M. Fitzgerald, G. Guo, R. McCracken, T. Tolley, and S. Klahr
ACE inhibition increases expression of the ETB receptor in kidneys of mice with unilateral obstruction
Am J Physiol Renal Physiol, January 1, 2003; 284(1): F209 - F217.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Fakhouri, S. Placier, R. Ardaillou, J.-C. Dussaule, and C. Chatziantoniou
Angiotensin II Activates Collagen Type I Gene in the Renal Cortex and Aorta of Transgenic Mice through Interaction with Endothelin and TGF-{beta}
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2701 - 2710.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. LEHRKE, R. WALDHERR, E. RITZ, and J. WAGNER
Renal Endothelin-1 and Endothelin Receptor Type B Expression in Glomerular Diseases with Proteinuria
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2321 - 2329.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
Tong Chuang Feng, Wang Yui Ying, Ren Jang Hua, Y. Y Ji, and M. de Gasparo
Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1): 19 - 24.
[Abstract] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. A. J. Frey, O. Grisk, N. Bandelow, S. Wussow, P. Bie, and R. Rettig
Sodium homeostasis in transplanted rats with a spontaneously hypertensive rat kidney
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1099 - R1104.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-J. Boffa, P.-L. Tharaux, S. Placier, R. Ardaillou, J.-C. Dussaule, and C. Chatziantoniou
Angiotensin II Activates Collagen Type I Gene in the Renal Vasculature of Transgenic Mice During Inhibition of Nitric Oxide Synthesis : Evidence for an Endothelin-Mediated Mechanism
Circulation, November 2, 1999; 100(18): 1901 - 1908.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. MERVAALA, B. DEHMEL, V. GROSS, A. LIPPOLDT, J. BOHLENDER, A. F. MILIA, D. GANTEN, and F. C. LUFT
Angiotensin-Converting Enzyme Inhibition and AT1 Receptor Blockade Modify the Pressure-Natriuresis Relationship by Additive Mechanisms in Rats with Human Renin and Angiotensinogen Genes
J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1669 - 1680.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
J. Maruyama, A. Yokochi, K. Maruyama, and S. Nosaka
Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats
J Appl Physiol, May 1, 1999; 86(5): 1687 - 1695.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Largo, D. Gomez-Garre, K. Soto, B. Marron, J. Blanco, R. M. Gazapo, J. J. Plaza, and J. Egido
Angiotensin-Converting Enzyme Is Upregulated in the Proximal Tubules of Rats With Intense Proteinuria
Hypertension, February 1, 1999; 33(2): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. R. Orth, J. P. Esslinger, K. Amann, U. Schwarz, M. Raschack, and E. Ritz
Nephroprotection of an ETA-Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, April 1, 1998; 31(4): 995 - 1001.
[Abstract] [Full Text] [PDF]